MedSystems Receives Merkur Award

The Merkur 2000, the Austrian award for innovation, has been presented to MedSystems Diagnostics GmbH (Rennweg, Austria) for its work in developing test systems that provide deeper insights into the process of apoptosis. These insights are expected to facilitate therapeutic advances in neurology, heart disease, cancer, and autoimmune diseases.

Apoptosis, or programmed cell death, is necessary for the normal development and homeostasis of multicellular organisms. Because diseases such as cancer are linked to the dysregulation of programmed cell death, apoptosis is of great interest in the study of neurologic disorders, autoimmune diseases, and tumor biology. The test systems of MedSystems provide insights into the mechanism of apoptosis that will aid the development of therapeutics for these disorders.

These signal transduction research kit are one element in the complete solution the company provides for researchers working in immunology and cell biology. In addition to these assay kits, the company also offers high-quality reagents and comprehensive technical support



Related Links:
MedSystems Diagnostics GmbH